Pharmacy News

Today's Pharmaceutical and Pharmacy News

Daily News Topic:

FDA News

3/15/10 - Eisai wins FDA approval for new Dacogen dosing

Eisai has reported that the FDA has approved a five-day dosing regimen for Dacogen for injection to treat patients with myelodysplastic syndromes, or MDS, a group of bone marrow diseases. The new outpatient dosing option provides physicians and patients with the flexibility of a dosing regimen with a reduced infusion time.

3/15/10 - Forensic Laboratories Develops First Oral Fluid Test for Tapentadol

DENVER, March 15Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug abuse, has unveiled the first oral fluid test for Tapentadol, a new federally approved drug prescribed by doctors for pain management. Tapentadol, approved by the FDA in late 2008, is considered a narcotic pain reliever used to treat modera

3/15/10 - Watson generic hypertension drug gets FDA approval

MORRISTOWN, N.J. -- Watson Pharmaceuticals Inc. said Monday a Florida subsidiary received government approval for a generic equivalent of the blood pressure drug Cardizem LA. Watson said the Food and Drug Administration approved an application for diltiazem hydrochloride extended release tablets, and the company intends to launch the generic immedi

3/15/10 - Watson Receives FDA Approval for Generic Cardizem(R) LA

MORRISTOWN, N.J., March 15Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. - Florida, has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International

3/12/10 - Boston Scientific wins FDA approval for Express LD iliac stent system

Boston Scientific, a medical device company, has reported that the FDA has approved its Express LD iliac premounted stent system for use in iliac arteries. The Express LD iliac stent is reportedly the first and only low-profile, premounted, balloon-expandable stent approved by the FDA for use in treating iliac artery disease.

3/12/10 - Bovie Medical Corporation Announces Clearance to Market Its ICON VS Electrosurgical Generator

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced the Company received clearance from the Food and Drug Administration to market its ICON VS electrosurgical generator. The fully digital ICON VS generator has a user-friendly touch-screen interface allowing the surgeon flexibility to choose from a var

Chain Drug Review

Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.

Featured Article from Chain Drug Review:

AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more